Skip to main content
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. — Investor Relations & Filings

Ticker · RKDA ISIN · US0390142042 LEI · 54930027ZPNA80B8O763 US Agriculture, forestry and fishing
Open in API
Filings indexed 564 across all filing types
Latest filing 2015-05-13 Regulatory Filings
Country US United States of America
Listing US RKDA

About Arcadia Biosciences, Inc.

https://arcadiabio.com/

Arcadia Biosciences, Inc. is a company focused on developing and marketing plant-based health and wellness products. With a foundation in agricultural innovation, the company cultivates next-generation ingredients and consumer goods. Its primary focus is a portfolio of specialty wheat ingredients designed to offer enhanced nutritional benefits, such as increased fiber, improved protein quality, reduced allergenic gluten, and higher amino acid content. Arcadia aims to transform wheat into a functional food ingredient, collaborating with food manufacturers to create healthier formulations of consumer products. In addition to its wheat ingredients, the company's brand portfolio includes Zola, a line of natural coconut water products.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2015
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to the U.S. Securities and Exchange Commission requesting acceleration of the effectiveness of a Registration Statement on Form S-1. It includes acknowledgments about the SEC's authority and the company's responsibilities, and signatures from company officers and underwriters. There are no financial statements, management discussion, or detailed financial data present. The document is a procedural filing related to the registration process for securities, specifically an acceleration request for a registration statement to become effective. This type of document is a regulatory filing related to securities registration and does not constitute an annual report, earnings release, or other financial report. Therefore, it fits best under the category of Regulatory Filings (RNS).
2015-05-13 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2015-05-11 English
Capital/Financing Update 2015
Capital/Financing Update Classification · 100% confidence The document is a letter from Orrick, Herrington & Sutcliffe LLP to the SEC staff responding to comments on a Registration Statement on Form S-1 filed by Arcadia Biosciences, Inc. The letter discusses amendments to the Registration Statement, including disclosures about stock ownership, dilution, use of proceeds, capitalization, and financial statement updates. It references the filing of Amendment No. 3 to the Form S-1 and includes details about compliance with SEC rules and audit opinions. The document is clearly related to the registration and offering process, specifically a Form S-1 registration statement, which is a capital raising filing. Therefore, this document is best classified as a Capital/Financing Update (CAP) because it pertains to the company's fundraising activities and amendments to the registration statement for an offering.
2015-05-11 English
S-1/A
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 3 to a Form S-1 Registration Statement filed with the SEC, which is a registration statement for an initial public offering (IPO). It includes a preliminary prospectus, details about the offering, underwriting, risk factors, management discussion, and financial data. The Form S-1 is a regulatory filing used to register securities for public sale and is not a financial report like an annual or quarterly report. It is not an announcement of a report but the actual registration statement document. Therefore, the filing type corresponds to a Capital/Financing Update (CAP), which covers company fundraising and financing activities such as IPOs and securities registration statements.
2015-05-11 English
Regulatory Filings 2015
Regulatory Filings Classification · 100% confidence The document is a formal letter from Arcadia Biosciences, Inc. to the U.S. Securities and Exchange Commission requesting acceleration of the effectiveness of a Registration Statement on Form S-1. It includes acknowledgments about the SEC's authority and responsibilities but does not contain financial statements, analysis, or detailed report content. The document is short (4701 characters) and serves as an announcement/request related to a regulatory filing rather than the filing itself. Therefore, it fits the category of a Regulatory Filing (RNS) as it is a formal communication with the SEC about the registration statement's status and effectiveness, not the actual registration statement or prospectus.
2015-05-09 English
Regulatory Filings 2015
Regulatory Filings
2015-05-08 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.